MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2026 International Congress

    Hip and Elbow Joint Angle Characteristics of Patients with Parkinson’s Disease

    D. Rasmiyani, A. Husni, E. Pasmanasari, A. Wati (Semarang, Indonesia)

    Objective: This study aimed to examine the hip and elbow joint angles during walking in Parkinson’s disease patients compared to healthy individuals. Background: Parkinson’s disease…
  • 2026 International Congress

    Perplexing Presentation of Myasthenia Gravis in an Elderly Patient with Essential Tremor and Parkinson’s Disease Complex Case Report

    I. Eltazi, B. Canibano, O. Suliman (Doha, Qatar)

    Objective: To highlight a complex clinical case of coexisting movement and neuromuscular junction (NMJ) disorders. Background: Essential tremor (ET) is the most common movement disorder…
  • 2026 International Congress

    Event-Locked Characterization of Movement-Related Beta Modulation using Synchronized Local Field Potentials and Video-Based Kinematics

    D. Hubers, BJ. Keulen, A. Vander Weide, BCM. van Wijk, PR. Schuurman, RMA. de Bie, M. Beudel (Amsterdam, Netherlands)

    Objective: Identifying physiomarkers of PD motor function beyond total beta power by examining event-related subthalamic nucleus beta modulation during continuous finger tapping (FT) using synchronized…
  • 2026 International Congress

    Opicapone Co-administration Allows Significant Flow Reduction in Continuous Subcutaneous Foslevodopa/Foscarbidopa Infusion: A Real-World Case Series

    G. Tabar Comellas, N. Lopez Ariztegui, M. Morales Casado (TOLEDO, Spain)

    Objective: To quantify infusion-flow reduction associated with concomitant use of opicapone in patients receiving LDp/CDp infusion and to describe dyskinesia and cutaneous tolerability outcomes during…
  • 2026 International Congress

    Rescue Electrode Implantation after Deep Brain Stimulation in Parkinson’s disease

    C. Lazaro-Hernandez, O. Brengaret, A. Cadena, J. Bejarano, A. Martinez, Y. Compta, A. Camara, A. Garrido, C. Painous, E. Muñoz, P. Roldan, J. Rumià, F. Valldeoriola, A. Sanchez (Barcelona, Spain)

    Objective: To describe patients with Parkinson’s disease (PD) who underwent a second deep brain stimulation (DBS) surgery with a different target as rescue therapy for…
  • 2026 International Congress

    Tremor-onset Parkinson’s Disease: Does Leg Tremor Portend a Poor Prognosis?

    D. Diaz, K. Mazinke, A. Rajput, A. Rajput, E. Noyes (Saskatoon, Canada)

    Objective: This study aims to assess the prognosis of baseline leg tremor-onset in autopsy-verified Parkinson’s Disease (PD) patients. Background: PD is a chronic neurological condition with a multifactorial etiology composed…
  • 2026 International Congress

    Disease-Modifying Outcomes Following High Intensity Boxing and Sensory Exercise in Parkinson’s Disease: Results From a Double-blinded Randomized Controlled Trial

    K. Sangarapillai-Patel, Q. Almeida (Waterloo, Canada)

    Objective: The purpose of this study was to determine whether high-intensity exercise (boxing) and sensory exercise (PD SAFEx™) produce disease-modifying effects on motor symptoms following…
  • 2026 International Congress

    Autonomic Coupling Patterns Differ by REM Sleep Behavior Disorder Status in De Novo Parkinson’s Disease

    B. Jin, J. Kim, S. Cheon (Busan, Republic of Korea)

    Objective: To investigate the relationships between autonomic dysfunction, clinical severity, and striatal dopaminergic deficits in de novo Parkinson’s disease (PD), and to determine whether these…
  • 2026 International Congress

    Probiotic Y7 Intervention Is Associated with Improved Motor, Gut-Related, and L-DOPA-Related Outcomes in a Rat Model of Parkinson’s Disease

    HY. Huang, TH. Yeh, SP. Tsao, DY. Wang, TJ. Chen (Taipei City, Taiwan)

    Objective: To evaluate whether probiotic Y7 intervention improves disease-related outcomes and influences L-DOPA-related responses in a 6-hydroxydopamine (6-OHDA) rat model of Parkinson’s disease (PD). Background:…
  • 2026 International Congress

    Peripheral Inflammatory Biomarkers as Predictive Indicator for Parkinson’s Disease: a Systematic Review and Meta-Analysis

    H. Hussien, A. Hegazi, A. Elsaid (Dakahlia, Egypt)

    Objective: To evaluate the association between peripheral inflammatory biomarkers and the incidence of Parkinson’s disease. Background: Parkinson’s disease is a progressive neurodegenerative disorder in which…
  • « Previous Page
  • 1
  • …
  • 4
  • 5
  • 6
  • 7
  • 8
  • …
  • 553
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley